r 64719 has been researched along with dipyridamole in 4 studies
Studies (r 64719) | Trials (r 64719) | Recent Studies (post-2010) (r 64719) | Studies (dipyridamole) | Trials (dipyridamole) | Recent Studies (post-2010) (dipyridamole) |
---|---|---|---|---|---|
15 | 0 | 0 | 7,826 | 881 | 632 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
O'Regan, MH; Phillis, JW; Walter, GA | 1 |
Barcelo, B; Ferrandon, P; Perche, JC; Schoffs, AR | 1 |
Brause, M; Delabar, U; Eckardt, KU; Gleiter, CH; Zebski, H | 1 |
Baldwin, SA; Cass, CE; Damaraju, V; Paproski, RJ; Tackaberry, T; Visser, F; Young, JD; Zhang, J | 1 |
4 other study(ies) available for r 64719 and dipyridamole
Article | Year |
---|---|
Effects of two nucleoside transport inhibitors, dipyridamole and soluflazine, on purine release from the rat cerebral cortex.
Topics: Adenosine; Animals; Biological Transport, Active; Brain Ischemia; Cerebral Cortex; Dipyridamole; Male; Piperazines; Purines; Rats; Rats, Inbred Strains | 1989 |
Effects of dipyridamole, soluflazine and related molecules on adenosine uptake and metabolism by isolated human red blood cells.
Topics: Adenosine; Chromatography, High Pressure Liquid; Dipyridamole; Erythrocytes; Flunarizine; Humans; In Vitro Techniques; Piperazines | 1994 |
Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats.
Topics: Adenine; Adenosine; Adenosine Diphosphate; Animals; Antihypertensive Agents; Carbon Monoxide; Dipyridamole; Diuretics; Drug Synergism; Enzyme Inhibitors; Erythropoietin; Gene Expression; Hypoxia; Kidney; Male; Oxygen; Phenethylamines; Phosphodiesterase Inhibitors; Piperazines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger; Theophylline; Vasodilator Agents; Xanthines | 1997 |
Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
Topics: Adenosine; Biological Transport; Dilazep; Dipyridamole; Enzyme Activation; Equilibrative Nucleoside Transporter 1; Humans; Kinetics; Models, Biological; Mutation; Nucleosides; Piperazines; Protein Binding; Thioinosine; Tryptophan; Vasodilator Agents | 2008 |